1 Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:globocan estimates of incidence and mortality world-wide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249. 2 孟群,刘爱民.国家疾病分类与代码(ICD-10)应用指导手册[M].北京:中国协和医科大学出版社,2017:1-1597. 3 中国鼻咽癌临床分期工作委员会.中国鼻咽癌分期2017版(2008鼻咽癌分期修订专家共识)[J].中华放射肿瘤学杂志,2017,26(10):1119-1124. 4 国家癌症中心.中国肿瘤登记工作指导手册[M].北京:人民卫生出版社,2016:47-51. 5 He ML,Luo MX,Lin MC,et al.MicroRNAs:potential diagnostic markers and therapeutic targets for EBV-associated nasopharyngeal carcinoma[J].Biochim Biophys Acta,2012,1825(1):1-10. 6 Wang Y,Zhang Y,Ma S.Racial differences in nasopharyngeal carcinoma in the United States[J].Cancer Epidemiol,2013,37(6):793-802. 7 Zheng RS,Zhang SW,Zeng HM,et al.Cancer incidence and mortality in China,2016[J].J Natl Cancer Center,2022,2(1):1-9. 8 Ji MF,Sheng W,Cheng WM,et al.Incidence and mortality of nasopharyngeal carcinoma:interim analysis of a cluster randomized controlled screening trial(PRO-NPC-001)in southern China[J].Ann Oncol,2019,30(10):1630-1637. 9 陈海珍,岳增军,陈建国,等.2002-2012年南通市肿瘤医院癌症住院患者分布特征[J].中华肿瘤防治杂志,2015,22(11):6-12. 10 武鸣,韩仁强,周永林,等.江苏省恶性肿瘤报告2017[M].南京:南京师范大学出版社,2018:41-44. 11 雷林,尚庆刚,刘维耿,等.2001-2015年深圳市鼻咽癌流行现况和时间趋势[J].中华肿瘤防治杂志,2019,26(20):1499-1503. 12 赫捷,魏文强,张思维,等.2018中国肿瘤登记年报[M].北京:人民卫生出版社,2019:90-93. 13 王雷,张云宵,杨柳,等.2005-2013年中国肿瘤登记地区鼻咽癌发病和死亡分析[J].实用预防医学,2020,27(2):145-149. 14 张娜,胡春宏.PD-L1 的表达和肿瘤退缩率对鼻咽癌预后的影响[J].中南大学学报(医学版),2020,45(11):14-20. 15 Tabuchi K,Nakayama M,Nishimura B,et al.Early detection of nasopharyngeal carcinoma[J].Int J Otolaryngol,2011,2011:638058. 16 Tang LQ,Lu TY,Li Y,et al.Patterns of failure and survival trends of 720 patients with stage I nasopharyngeal carcinoma diagnosed from 1990-2012:a large-scale retrospective cohort study[J].J Cancer,2018,9(7):1308-1317. 17 Haberer-Guillerm S,Touboul E,Huguet F.Intensity merlnlaterl radiation therapy in nasopharyngeal carcinoma[J].Eur Ann Otorhinolaryngol Head Neck Dis,2015,132(3):147-151. 18 何文龙,吕炎,胡云扬,等.放射联合药物治疗鼻咽癌的现状[J].实用癌症杂志,2019,34(2):346-348. 19 杨开炎,韦永昌,杨秋云,等.鼻咽癌的免疫治疗研究进展[J].实用肿瘤学杂志,2021,35(6):542-546. 20 Luo W,Yao K.Molecular characterization and clinical implications of spindle cells in nasopharyngeal carcinoma:a novel molecule-morphology model of tumor progression proposed[J].PLoS One,2013,8(12):e83135. 21 Luo WR,Gao F,Li SY,et al.Tumour budding and the expression of cancer stem cell marker aldehyde dehydrogenase 1 in nasopharyngeal carcinoma[J].Histopathology,2012,61(6):1072-1081. 22 Cabezas-Camarero S,Pérez-Segura P.Liquid biopsy in head and neck cancer:current evidence and future perspective on squamous cell,salivary gland,paranasal sinus and nasopharyngeal cancers[J].Cancers(Basel),2022,14(12):2858. 23 Huang T,Ploner A,Chang ET,et al.Dietary patterns and risk of nasopharyngeal carcinoma:a population-based case-control study in southern China[J].Am J Clin Nutr,2021,114(2):462-471. 24 Zheng MQ,Wang TM,Liao Y,et al.Nasopharyngeal Epstein-Barr virus DNA loads in high-risk nasopharyngeal carcinoma families:familial aggregation and host heritability[J].J Med Virol,2020,92(12):3717-3725. |